Position in KRYS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,223,164
+$406,358 QoQ
Shares Held
3,291
+4.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#185
of 419 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Derivatives in KRYS
reported options exposure · as of Jun 30, 2020CallValue
$608,874
CallShares
14,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $701,516,965 across 82 Biotechnology names. KRYS ranks #33 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
427,448 | $212,326,240 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
942,432 | $73,764,150 | |
| 3 | ARGX |
Argenx SE
|
77,213 | $71,635,902 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
103,247 | $64,378,631 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
242,063 | $58,329,919 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
515,981 | $28,347,995 | |
| 7 | MRNA |
Moderna, Inc.
|
389,789 | $27,296,921 | |
| 8 | CYTK |
Cytokinetics Inc
|
285,688 | $24,337,759 |
All Filings in KRYS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,223,164 | 3,291 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $816,806 | 3,162 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $550,029 | 2,231 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $411,136 | 2,329 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $605,785 | 4,407 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $796,565 | 4,418 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $520,894 | 3,325 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $572,665 | 3,146 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $539,166 | 2,936 | Shares | Defined | 2024-08-14 | |
| 2022-12-31 | $1,718,915 | 21,698 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $1,508,168 | 21,638 | Shares | Defined | 2022-11-10 | |
| 2021-03-31 | $37,826 | 491 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $125,640 | 2,094 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $26,949 | 626 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $608,874 | 14,700 | Call | Defined | 2020-08-12 | |
| 2020-06-30 | $39,721 | 959 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||